en

PRODUCT DETAIL

Roxampex 10 mg/5 mg/8 mg filmom obalené tablety

Code 2836D
MA number 58/0364/19-S
Product Form: tbl flm 90x10 mg/5 mg/8 mg (blis.OPA/Al/PVC/Al)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
Therapeutic Class: 58 - HYPOTENSIVA
ATC:
C CARDIOVASCULAR SYSTEM
C10 Lipid modifying agents
C10B Lipid modifying agents, combinations
C10BX HMG CoA reductase inhibitors, other combinations
C10BX14 Rosuvastatin, amlodipine and perindopril
Shelf life: 36
Container: blister OPA/Al/PVC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10b fixed combination application
MA issued: 22.11.2019
Validity: 22.11.2024
MA renewed: Renewal application submitted
PIL: PIL_Roxampex_06/2023.pdf  
SPC: SPC_Roxampex_06/2023.pdf  
Safety feature Yes
Data update: 15.01.2020
eu-flag.png sk-flag.png